And, at the same time, cancer cells with TP53 benefit from enhanced evolvability, which increases both the numbers of drug selectable self-renewing cancer cells and their mutational genetic diversity, tipping the numbers game, and probability, heavily in favour of resistance (Fig. 3). Here, TP53 is linked to cancer.